A new US colic study, published in Equine Veterinary Journal (EVJ), in partnership with the American Association of Equine Practitioners, has identified various risk factors, including delayed faecal output and increasing blood lactate, associated with post-anaesthetic colic.
The study Risk factors associated with gastrointestinal dysfunction in horses undergoing elective procedures under general anaesthesia was conducted by surgeons based at the College of Veterinary Medicine and Biomedical Sciences at Colorado State University, USA.
The authors say that the research should enable vets to implement preventative measures to help reduce incidences of colic in the future.
Gastrointestinal pain has been estimated to occur in 2.8-6% of horses following general anaesthesia for elective procedures, the most common cause being impaction of the large intestine or caecum.
The medical records of 416 horses undergoing general anaesthesia were collected over a two-year period and the potential risk factors were examined. 8.7% of horses were diagnosed with gastrointestinal dysfunction - higher than previous estimates probably because the study included horses requiring treatment for decreased faecal output whereas previous studies did not. Potential risk factors were assessed, including faecal output, which was decreased in 38.9% of cases, blood lactate, position during surgery, rectal temperature and breed of horse.
The results showed that Arabian horses, increasing blood lactate, right lateral recumbency, decreased rectal temperature post-procedure and delayed passage of faeces were significantly associated with an increased risk of gastrointestinal dysfunction.
Diana Hassel, who instigated the study, said: "These findings should help the clinician identify higher risk horses and be proactive about their management in the post-anaesthetic period.
"This may include pre-emptive nasogastric intubation and administration of mineral oil and/or water and electrolytes. Although core temperature control in horses is difficult to achieve in adult horses during surgery, further research into this field may prove beneficial."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "This study brings obvious and immediate practical benefits for clinicians and the horses under their care. Rigorous monitoring of higher risk surgical cases should lead to a reduction in incidences of post-operative colic, making recovery procedures less difficult and outcomes more favourable."
A study published in Current Biology has demonstrated that there are remarkable similarities in the way that dog and human brains respond to sound, and that dog brains, like those of people, are also sensitive to acoustic emotional cues.
Lead by Attila Andics, researchers from MTA-ELTE Comparative Ethology Research Group in Hungary trained 11 dogs to lay motionless in an fMRI brain scanner. This made it possible to run the same neuroimaging experiment on both dog and human participants - something that had never been done before. They captured both dogs' and humans' brain activities while the subjects listened to nearly 200 dog and human sounds, ranging from whining or crying to playful barking or laughing.
The resultant scans showed that dog and human brains include voice areas in similar locations. Not surprisingly, the voice area of dogs responds more strongly to other dogs while that of humans responds more strongly to other humans.
The researchers also noted striking similarities in the ways the dog and human brains process emotionally loaded sounds. In both species, an area near the primary auditory cortex lit up more with happy sounds than unhappy ones. Andics says the researchers were most struck by the common response to emotion across species.
There were some differences, too: in dogs, 48% of all sound-sensitive brain regions respond more strongly to sounds other than voices. That's in contrast to humans, in which only 3% of sound-sensitive brain regions show greater response to nonvocal versus vocal sounds.
The researchers say that the findings suggest that voice areas evolved at least 100 million years ago, the age of the last common ancestor of humans and dogs. It also offers new insight into humans' unique connection with our best friends in the animal kingdom and helps to explain the behavioural and neural mechanisms that made this alliance so effective for tens of thousands of years.
Andics said: "This method offers a totally new way of investigating neural processing in dogs. At last we begin to understand how our best friend is looking at us and navigating in our social environment."
Photograph: Borbala Ferenczy. Dogs at the MR Research Centre (Budapest).
Organisers of The Vet Charity Challenge, which last year raised £50,000 for charity, have announced that the event will take place Saturday 27th September 2014 in Pewsey, near Marlborough, Wiltshire.
The event consists of teams of four walking/running, cycling and kayaking as well as some orienteering and mental and physical tasks.
Registration will open at the start of April. Organisers say that spaces are limited and in 2013 filled up very fast, so early booking is advisable.
The charities being supported in 2014 will be Hearing Dogs for Deaf People, SPANA and Cats Protection.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse and Vetoquinol and supported by the VMPA and Veterinary Practice magazine.
For more information visit www.vetcharitychallenge.co.uk.
Novartis Animal Health has launched 'The Wormer Decision Tree', an online tool to help veterinary surgeons in giving sheep farmers the most up-to-date advice about worming.
Lesley Stubbings, SCOPS representative and Independent Sheep Consultant said: “Choosing the right wormer group is hugely important and there remains much confusion especially when it comes to anthelmintic resistance.
“Worms, including resistant and multi-resistant species, are threatening the productivity of sheep farms. However with a well-thought-out worming strategy that uses both the new wormer groups, in association with existing wormers, it is possible to slow resistance.”
Results of the Farming Against Wormer Resistance (FAWR) campaign survey, conducted in 2013, revealed growing concern about wormer resistance among farmers - but confusion about the best course of action to take.
Fiona Anderson, Novartis Animal Health Veterinary Manager said: "This tool has been developed adhering to SCOPS principles and is designed to ensure a consistent responsible approach is used when prescribing anthelmintics.
"Available only to SQPs and vets, it will be a valuable tool to train new staff and use with farmers, to explain which of the five drench classes are appropriate for particular sheep groups at specific times of year."
The Novartis Wormer Decision Tree asks three key questions: the type of sheep being dosed, the purpose of the dose, and the farm's resistance status. It then produces a recommendation of the required active ingredient, along with more detailed information to support the recommendation. There is also a calculator which provides a dose rate and cost per dose based upon the recommendation.
To use the decision tree, you must first register on the Novartis Farm Animal Health website: www.farmanimalhealth.co.uk. Then head here: www.farmanimalhealth.co.uk/wormerdecisiontree
Dechra Veterinary Products has launched Anesketin, an anaesthetic licensed for cats, dogs and horses.
Anesketin contains ketamine 100mg/ml solution for injection and is indicated for induction of anaesthesia. In cats, it can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required.
Dechra Brand Manager Carol Morgan said: "Anesketin is a versatile product which can be used as a sole agent in cats or in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction and maintenance of anaesthesia.
Anesketin is available in 10 ml vials. The withdrawal period for meat, offal and milk is one day and the product does not require any special storage conditions.
For further information, visit www.dechra.co.uk
The Animal Welfare Foundation (AWF) has produced a leaflet which guides pet owners through the euthanasia decision making process.
The leaflet 'Saying goodbye - the ultimate kindness' explains why euthanasia may be the most caring option, the choices owners have, the different ways euthanasia may be performed and what happens next. It also addresses the emotions owners may go through when deciding to put their pet down.
AWF Chairman Tiffany Hemming said: "As vets we often see pet owners struggle with letting their pet go. Guilt may be the strongest emotion owners feel when deciding to put their pet down. We wanted to guide owners through this difficult time in a sensitive way and encourage them to ask questions and work with the vet to help them come to terms with the end of their pet's life.
"While the leaflet is aimed at pet owners we hope vets find it a useful communication tool during this distressing time for their clients."
To see all AWF leaflets including 'Pre- and post-operative care', 'Pet travel', 'Pets and poisons', and 'What makes my pet happy' visit http://www.bva-awf.org.uk/pet-care-advice.
Practices can order batches of the leaflets for clients in return for a donation to AWF by contacting bva-awf@bva.co.uk.
Zoetis has announced the launch of Apoquel (oclacitinib maleate), a new treatment for pruritus associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis.
Uniquely, the new treatment inhibits the JAK enzyme, a protein that is integral to the signalling pathway of cytokines that are pro-inflammatory or have a role in allergic and itch response.
According to the company, pruritus affects about one in six dogs whose owners seek veterinary help, and about half of all itchy dogs will have an underlying allergic skin condition for which the new product would be indicated.
Zoetis says that because Apoquel targets the specific pathways of pruritus (itch) and inflammation, it is less likely to cause unwanted side effects than glucocorticoids and demonstrates anti-pruritic efficacy within four hours.
Pascal Prélaud, a dermatology specialist from Paris, who took part in the clinical development programme of Apoquel, said: "When a dog develops an itch related to an allergy, it can be life-disrupting for the dog and the entire family. I've learned firsthand the fundamental difference this treatment can make to a dog and its owners in stopping the itch, but without many of the side-effects that are common with steroids.
Zoetis reports that in clinical trials, Apoquel demonstrated a good safety profile and efficacy for the treatment of pruritus and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners within 24 hours of administration, and pruritus continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinarians were significantly improved after one week and continued to improve long term during the studies (four months).
Apoquel is a POM. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium- to long-term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Ceva Animal Health has launched Vectra 3D, a broad spectrum topical ectoparasiticide for dogs which is effective against fleas, ticks and flies.
Vectra 3D contains a formulation of a brand new active called dinotefuran, pyriproxyfen and permethrin.
According to the company, Vectra 3D provides a rapid flea kill within two hours for dogs on current treatment and complete protection against the major vectors: fleas, ticks, sand flies, mosquitoes and stable flies1. Additionally, because dinotefuran kills on contact, it is claimed to reduce the incidence of flea feeding1.
Vectra 3D is applied in a line from the base of the tail to the neck using a patented applicator with an elongated tip, designed to make it easy to apply the product through the hair directly onto the skin. The applicator is also designed to provide accurate dosing without making any mess, as nothing comes out until the tube is squeezed.
Ceva highlights that the number of people travelling with their pets has increased by 61% since 20122, and that Vectra 3D is the only topical ectoparasiticide that offers repellent action against sand flies for one month, together with protection against mosquitoes and stable flies.
Julia Wood, product manager at Ceva Animal Health said: "Vectra 3D is an innovative formulation which uses a unique, easy-to-administer applicator to provide complete protection against fleas, ticks and flies. And with spring nearly upon us, it's time to start talking to clients about flea treatments, such as Vectra 3D."
To support the launch of Vectra 3D, Ceva is hosting a series of CPD meetings at venues across the UK. Accounting for two hours CPD, the afternoon meetings will cover vector-borne diseases, the importance of ticks in the UK and product information on Vectra 3D. They will be presented by Ian Wright BVMS BSc MSc MRCVS and Richard Wall BSc MBA PhD FRES and take place at:
For further information, contact your Ceva Animal Health territory manager or email Ceva Animal Health on customerservicesuk@ceva.com.
Bayer Animal Health has announced the results of a survey1 which shows that despite 80% of dog owners being aware of lungworm (Angiostrongylus vasorum), 85% of dogs remain unprotected against the parasite.
The survey, which was carried out amongst 1,000 dog owners, also found that more than 5% had encountered lungworm in their own dogs. However, only 15% of owners treat their pet against parasites on a monthly basis, with the remainder admitting to missed routine lungworm worming treatments or not treating at all.
Bayer highlights evidence from the Royal Veterinary College2, which confirms the lungworm parasite has spread across the UK from its traditional habitat in the south of England and Wales, and is now widespread in Central England, also reaching northern regions and Scotland, with one in five vet practices nationwide reporting at least one case of the parasite. In another survey of 150 veterinary practices across the UK a total of 952 suspected cases were reported (157 laboratory confirmed), with 81 deaths thought to have been caused by the parasite3.
To encourage more pet owners to take action, Bayer will launch a consumer campaign called 'Act on Lungworm' in March. The campaign will include the world's first 24-hour radio station for dogs and their owners, 'Hound Waves', broadcasting live from Crufts on Friday 7th March. The event will also see the launch of a new television and advertising campaign from Bayer.
For veterinary professionals, the campaign launch will also include online videos detailing the 'ACT on Lungworm' veterinary support and showing the new television advertisement exclusively to vets before the national launch.
Caroline Braidwood, Group Product Manager at Bayer Animal Health said: "After launching the 2013 lungworm awareness campaign and providing owners with a social media platform, we quickly began to recognise the enthusiasm that exists to encourage action.
"We received feedback from owners who had tragically lost their pets to lungworm, and whilst we were pleased that we were helping to raise awareness, we became conscious that we needed to do more to prevent dogs from dying unnecessarily. Our 2014 campaign focus has come as a direct result of talking to these owners and providing individuals like Sandra Stevens with a platform to discuss their experiences in the hope that more owners will take action before it is too late."
'ACT on Lungworm' is part of Bayer Animal Health's wider 'It's a Jungle Out There' parasite protection initiative. Further information is available at www.facebook.com/jungleforpets
References
Novartis Animal Health has announced the launch of a campaign to improve awareness of and improve education about atopic dermatitis (AD), to coincide with the 10th anniversary of Atopica.
As part of the campaign, the company is inviting veterinary surgeons to take part in an online survey for the chance to win an iPad mini: www.surveymonkey.com/s/atopica
In addition, Novartis says it will be offering all sorts of new educational materials for both vets and owners, including research into current trends and attitudes towards AD, insights from experts in the field, and case studies.
Ricardo Garvao, Category Manager for Atopica said: "This year marks an important milestone for the Atopica brand that wouldn't have been possible without the backing of so many vets. Continued investment by Novartis Animal Health into research and education seems a fitting way to extend thanks for this support and so forms one of the key elements of the 'Decade of Comfort' campaign. I am constantly amazed at just how dedicated and hard-working vets are and am immensely proud that Novartis Animal Health shares their goal to help pets remain happy and healthy."
Vetsonic has taken over the marketing of Cavalesse, the oral nutritional supplement for horses that are prone to skin allergies, such as sweet itch.
Cavalesse contains a formulation of water-soluble vitamins and minerals, administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat. Vetsonic claims the supplement helps horses maintain a healthy skin and promotes normal immune function.
Ray Rochester, Managing Director of Vetsonic said: "It's an exciting phase in the development of Vetsonic which will see us rapidly expanding in the increasingly competitive small animal and equine market. Cavalesse is a welcome addition to our portfolio."
For further information, contact Vetsonic customer services on 01653 695333.
Zoetis has launched PetDialog and HorseDialog, the only treatment reminder apps for pet and horse owners which veterinary practices can customise with their own branding.
The app is downloadable from the Apple and Android app stores, but is only accessible by inputting a unique practice identity code.
Once the app is unlocked, owners can then input details of any medications their pet is taking and the date its healthcheck / vaccinations are due, after which they'll receive a practice-branded email reminder.
It's a similar idea to Bayer's reminder app released earlier this year, but with the very clever addition of practice branding.
John Toole, Product Manager at Zoetis said: "This is absolutely the right time to launch this app. Smartphone ownership has rapidly increased from 38% to 60% in the last three years and by 2015 it is predicted that 73% of the UK population will own a Smartphone. The use of Smartphones is no longer just the domain of the young - use and ownership is pretty evenly spread among age groups between 24 and 64, with greatest growth among the 44 -74 age group over the past three years. It comes as no surprise that recent market research confirms 57% of UK pet owners own an Android or iOS device.
"Health businesses are the most trusted by UK mobile users when it comes to receiving mobile messages. More than 11 million consumers have opted in to receive mobile messages from health companies, particularly to take advantage of appointment reminders. This form of communication can really boost loyalty where vet practices are concerned, as 74% of users say that mobile messages that had a use or benefit would maintain or enhance their loyalty to that brand.
"PetDialog has been a significant investment for us and with the help of our customers we plan to re-invest in a robust development stream to ensure the app becomes a valuable tool for pet owners and practices alike. To help practices launch and market the app we've developed an extensive bespoke range of marketing support materials from web pages and email templates to practice posters that come alive in the waiting room with augmented reality."
VetSurgeon gave the app a very quick trial. We found registration simple and easy. Clear navigation. Very good first impression.
Except ...
Honestly, whose idea was it that even the most pathologically insane pet owner would possibly, even once in a million years, want to record (and chart) the amount of time they spend hugging their pet. And not just that, but also to categorise their pet-hugging activities according to whether it was 'Morning Cuddles', 'Afternoon Hugs' or 'Evening Snuggles'. Someone at Zoetis' digital agency must have been smoking something very strong when they came up with that one.
Similarly, the ability to record the amount of time spent playing with the dog, breaking it down into specific activities such as: 'Fetch', Tug of War', 'General Playing', is surely targeted at the 0.0000000001% of the pet owning population that really should be getting some sort of professional help.
That said, the overall idea and execution is top notch. Provided Zoetis removes the madder elements of the app at the next upgrade, it'll get 5 stars out of 5. Meantime, it's still highly recommended.
For more information about the app, contact your Zoetis Account Manager
Sogeval has launched Efex, a marbofloxacin tablet designed for veterinary use.
Efex tablets are available in three blister pack sizes of 10mg, 40mg and 100mg that break into halves for cats and halves and quarters for dogs, facilitating accurate dosing for a wide range of patients.
In cats, the flavoured chewable 10 mg tablets allow accurate dosing of 2.5kg and 5kg cats at 2mg/kg once daily. In dogs the 40mg four way break tablet is designed for a 20 kg dog and the 100mg for a 50kg dog.
Efex tablets are chewable and sogeval says that in a palatability study 7 out of 10 cats readily consumed them.
Each tablet contains a broad-spectrum fluoroquinolone antibiotic marbofloxacin for oral administration, which is readily absorbed reaching maximal plasma concentrations within two hours. It exhibits a wide range of activity against gram-negative and gram-positive bacteria, including Pseudomonas spp and Mycoplasma spp.
Purina has launched a range of services and support materials to help veterinary professionals approach the subject of nutrition with owners.
The Gastrointestinal Support Pack includes a GI handbook, "lunch and learn" educational sessions, a diagnostic support tool (available at www.purinavets.eu/giapplication) and a toolkit containing information sheets and diagnostic advice.
The company has also announced the result of some consumer research it conducted through One Poll in 2013, which revealed that 77% of dogs have experienced some form of digestive health issue, but only 20% of owners had visited their vet to discuss it. The research also found that 80% of owners would be willing to change their pet's diet if it would improve their digestion.
Esther Rawlinson, Purina UK Veterinary Affairs Manager said: "GI upsets and associated 'accidents' can be really distressing for both owner and pet but are seemingly suffered as 'just one of those things' by many. This needn't be the case though, as a lot of GI-related conditions could be prevented or at least managed by the correct nutritional advice and a specially formulated veterinary diet. By addressing nutrition at every consultation, vets can better identify those patients who suffer regular GI disturbance but whose owners do not feel it worthy of mentioning when in the clinic. The survey results show that there is a huge opportunity for vets to improve the health of many more of their clients' dogs and this is why Purina has introduced a range of GI services and support materials. We aim to help vets to include a nutritional assessment in all of their consultations."
For more information call PURINA PetCare Team on 0800 212 161.
The Veterinary Benevolent Fund has launched a new campaign to get a sticker displaying the organisation's helpline telephone number for veterinary professionals in every practice.
The charity has produced a video which explains why.
http://vimeo.com/80551830
Do you have a VBF sticker displayed in your practice? If not, you can order one today. Visit www.vetlife.org.uk
The Kennel Club has announced that it now recognises the Portuguese Pointer, bringing the total number of recognised pedigree breeds in the UK to 212.
The Portuguese Pointer is only the second new breed to be recognised by the Kennel Club in the last five years.
However, as exotic dog breeds have risen in popularity, the Kennel Club reports that many native breeds have fallen out of favour and have been put on its list of 'vulnerable native breeds'; those with less than 300 annual puppy registrations which could disappear from our streets and parks if their numbers continue to decline.
New statistics released by the Kennel Club have shown that whilst vulnerable native breeds have increased in number this year, certain breeds such as the Sealyham Terrier and Otterhound continue to decline. Recent years have seen the Old English Sheepdog and English Setter enter the 'at watch' list. Furthermore, with just 239 Pembroke Corgi registrations so far this year, it is feared the Queen's favourite breed could also become vulnerable for the first time.
By contrast, exotic breeds such as the French Bulldog and Smooth Coated Chihuahua (originally from Mexico) are increasing in popularity with 4,843 and 2,931 registrations respectively so far this year. Between 2003 and 2012 the breeds have increased by 1,232% and 700% respectively.
When the first ever Kennel Club stud book was produced in 1874, just 43 breeds were listed, including many native breeds that are now considered to be vulnerable, such as the Dandie Dinmont Terrier, Clumber Spaniel, Otterhound and Skye Terrier.
Some native breeds continue to thrive, including the English Springer Spaniel, the Cocker Spaniel, the Staffordshire Bull Terrier, the Bulldog, the Golden Retriever, and the Border Terrier, all top ten breeds. But others in the top ten are from abroad.
Visitors to Discover Dogs, which is taking place at Earls Court on November 9th and 10th will be able to meet more than 200 breeds of dog under one roof, including the vulnerable breeds and the latest pedigree dog breeds in the UK.
The newly added Turkish Kangal Dog will also be coming to the event. This breed was added earlier this year and was the first new breed to join the Kennel Club register in almost five years. The Greater Swiss Mountain Dog, officially recognised from 1 October 2008, was the last dog recognised by the Kennel Club prior to the two new additions for this year. Organiser of the Kennel Club's Discover Dogs event, Vanessa McAlpine, said: "The UK is lucky to have so many wonderful dog breeds, and at our Discover Dogs event people have a unique opportunity to meet more than 200 of them, including those that might never cross your path in day to day life because they are so rare, those that are new to our shores and those that have been working with people in Britain for hundreds of years."
To find out more about Discover Dogs, visit www.discoverdogs.org.uk/.
Vétoquinol has launched Flexadin, a new range of joint support products for cats and dogs with osteoarthritis (OA)
Robert Simpson, Flexadin Product Manager said: "This new range is made up of two products: Flexadin Plus and Flexadin Advanced, both are dietetic complementary feeds which are members of a small group of joint support products which contain Omega-3 fatty acids and Vitamin E. These ingredients are proven to aid the support of the metabolism of joints in the case of OA. Although many different joint support aids are available, not all of them contain these extra ingredients."
Vétoquinol says that in addition to Omega-3 fatty acids and Vitamin E, Flexadin Plus contains the traditional ingredients: glucosamine, chondroitin and devil's claw. Flexadin Advanced contains the novel ingredient, UCII - a type of undenatured type II collagen which has been manufactured using a patented process.
Flexadin Plus comes in two formulations, the first is specifically designed for cats/small dogs and the other is for medium/large dogs. Flexadin Advanced is specifically for dogs.
Robert added: "Flexadin Advanced has a specific property which means that the administration rate is only one chew per day whatever the weight of the dog. This has an important impact on the price per day for medium and large dogs which may require more than one tablet of traditional joint support products. This property also makes Flexadin Advanced a convenient option for owners. In addition to this benefit, UCII is becoming more and more popular due to the results of scientific studies in dogs, horses and even humans.
"We are all very excited about the advances this range can bring to veterinary practices."
Both Flexadin Plus and Advanced are presented as palatable, shaped, soft chews which come in zip-lock packs to keep the soft chews fresh and tasty. Flexadin Plus comes in packs of 90 chews whilst Flexadin Advanced comes in packs of 30 chews.
For further information about Flexadin, contact Vétoquinol on: 01280 825424.
Bimeda has launched Recocam, a 20mg/ml meloxicam preparation licensed for use as a single injection course in cattle, horses and pigs.
Bimeda's Head of Technical Services, Padraig Hyland MVB said: "Meloxicam's anti-inflammatory credentials and safety profile is well proven and it remains rightly popular with large animal vets. With our manufacturing expertise it makes sense to add this widely used product to our portfolio. Our aim is to provide a comprehensive range of both established standards and new innovative products for cattle and equine vets, and this is just another step in that process."
Bimeda says Recocam has a broad range of indications including acute respiratory infections, in combination with oral re-hydration in diarrhoea therapy and acute mastitis, for non-infectious locomotor disorders and lameness in pigs and alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders and pain relief associated with equine colic. In cattle Recocam can be given by single subcutaneous or intravenous injection.
A groundbreaking 3d printing service offered by Replica 3DM, a spin off of Salisbury NHS District Hospital, has helped referral veterinary orthopaedist Andy Moores in carrying out surgery on dog that won the 2013 Crufts Friends For Life Award.
Haatchi is an Anatolian shepherd dog whose back left leg and tail were amputated after he was tied to a railway line and hit by a train. As a rescue dog, he was adopted by the family of a young boy called Owen Howkins from Basingstoke. Owen has Schwartz‐Jampel syndrome, which causes his muscles to be permanently tense. The two bonded and became inseparable.
Earlier this year Haatchi developed mobility issues with his remaining hindlimb. He was referred to Anderson Moores Veterinary Specialists, in Hampshire, where a laterally luxating patella was diagnosed. The patella luxation was a result of a complex deformity of the femur and the tibia. Surgery was needed to enable Haatchi to use his leg better.
Replica 3DM, which normally uses its £70,000 printing equipment to make models of human bones and joints, created a 3d model of Haatchi’s hind leg from hip to paw. Normally the company charges around £200 for a human mandible. So, in order to keep costs down, it suggested a scaled down model which would still make Andy's preoperative planning a lot more straightforward and would help identify the correct surgical approach and likely abnormalities which would be encountered. Andy emailed the CT scans to Matt Sherry from Replica 3DM Ltd who converted them into a 3D model of Haatchi’s leg. Production of the model took six hours.
Andy said: "Having access to a scale 3D model of Haatchi's limb prior to surgery not only allowed us to better understand his deformity but it also allowed us to practice the femoral and tibial corrective osteotomies prior to surgery to be sure they would achieve what we intended."
Replica 3DM Ltd is based at Salisbury District Hospital and provides a service producing 3 dimensional products used in various types of surgery e.g. fractured neck of femur, cranioplasty procedures and jaw fractures. The company says that while of course not necessary in all procedures, visualisation of fractures and deformities prior to surgery can help in pre planning of surgery, reducing costs in time and equipment as well as enabling smaller incisions and less soft tissue intervention, so that patient recovery is enhanced.
For more information, visit www.replica3dm.com or ring Matt Sherry at Replica 3dm on 01722 429185.
Burgess Excel and the PDSA are urging veterinary surgeons and nurses to get their clients to sign up to the free PDSA Rabbit Wellbeing Challenge by the closing date of Friday 22 November.
According to the organisers, the PDSA Rabbit Wellbeing Challenge is designed to help all rabbit owners understand and meet their pets' five welfare needs - the five things that all pet rabbits' need to be healthy and happy. Since the campaign was launched in June, more than 1,000 rabbit owners have signed up to take the challenge, and veterinary practices are now being urged to ensure their clients take advantage of this free resource by visiting www.rabbitneeds.org.uk to register.
The Challenge website allows owners to take a monthly quiz to find out how well they are currently meeting their rabbits' needs, with advice on how to further improve their health and wellbeing. At the end of the challenge, owners will be presented with a Rabbit Wellbeing Challenge certificate and receive monthly vouchers together with money-off coupons for the Excel Feeding Plan. They will also be entered into a prize draw to win a 16gb iPad.
The Challenge is being featured on stickers on every pack of Burgess Excel Rabbit Nuggets. One million packs will have been sold by the final date for sign ups on the 22 November.
Burgess Pet Care Veterinary Surgeon, Suzanne Moyes, said: "With help from the veterinary community we really can make a difference by raising awareness about important rabbit welfare issues and in turn change rabbit owner behaviour. Working together, we are can improve the health and wellbeing of the UK's third most popular pet by educating pet owners, especially in relation to diet and regular veterinary check-ups."
Sean Wensley, Senior Veterinary Surgeon at PDSA, added: "Sadly, the welfare needs of pet rabbits are often not met. Common problems include a poor diet, living alone in a small hutch with no exercise run, and a lack of preventive healthcare. The PDSA Rabbit Wellbeing Challenge is a great tool for owners to assess how well they are currently meeting their rabbit's five welfare needs and to get advice on making practical, positive improvements. Most owners want their pets to be healthy and happy, and we hope this Challenge will help tackle some of the preventable health and welfare problems commonly seen in pet rabbits."
For further information on The PDSA Rabbit Wellbeing Challenge visit www.rabbitneeds.org.uk or for further details on the Burgess Excel Feeding Plan visit www.excelfedingplan.co.uk
The British Small Animal Veterinary Association has written to Public Health England to ask if they would be prepared to review their risk assessment for front line staff in veterinary practices (i.e. veterinary surgeons, veterinary nurses and receptionists) regarding pre-exposure rabies vaccination.
The letter points out that the changes to the Pet Travel Regulations, brought in on 1st January 2012, make it possible for dogs, cats and ferrets to enter the UK from an EU country only 21 days after vaccination, with no requirement for blood testing and a 6-month wait.
The risk assessment undertaken by Defra at that time acknowledged that this would lead to an increase in the risk of introducing rabies to the UK, but this risk was still considered to be very low.
However, this risk assessment made a number of assumptions, including that there would be full compliance with the regulations. Since that time it has become apparent that not only have these changes led to a significant increase in the number of animals entering the UK, but that a number of these animals do not fully comply with the regulations.
According to BSAVA, current evidence suggests that increasing numbers of puppies enter the UK from abroad, particularly Eastern Europe, and that these are often presented with illness at veterinary practices by their new, and often unsuspecting, owners. While it has been assumed that animals entering under the Pet Travel Scheme pose a low risk of carrying rabies, the recent case of two puppies imported into The Netherlands from Bulgaria which tested positive for rabies indicates that the disease may occur even in puppies that were vaccinated and travelling legitimately.
While a great deal has been achieved in the control of rabies in the EU, there is increasing expansion in member states to include countries such as Bulgaria and Romania in which rabies remains endemic. Moreover, sporadic cases continue to occur in countries within this region (i.e. Italy and Greece). Animals imported into the UK from these regions could potentially introduce rabies into the United Kingdom.
While importation of affected animals remains a remote possibility, the likelihood is that an affected animal would present for veterinary treatment and that frontline veterinary staff may be at greatest risk of exposure. Some veterinary practices that deal routinely with imported pets adopted from the street or animal shelters in other countries, have staff that may be at even greater risk.
BSAVA President Professory Michael Day, who signed the letter on behalf of the Association and its members, said: "As a result of the current conditions in which veterinary professionals find themselves, BSAVA, in our letter sent on 12 November, has urged Public Health England to consider adding veterinary staff who may come into contact with imported animals to the list of those entitled to receive pre-exposure rabies vaccination."
Boehringer Ingelheim Vetmedica has launched Semintra, a new liquid treatment for cats with chronic kidney disease (CKD).
The active ingredient in Semintra is telmisartan, the first angiotensin receptor blocker to be licensed in veterinary medicine.
Like benazepril, Semintra is indicated for the reduction of proteinuria associated with CKD in cats. Boehringer says it has a highly targeted mode of action that provides rapid and reliable reduction of proteinuria in cats with chronic kidney disease. The company adds that it is well tolerated and almost exclusively excreted in the faeces, so elimination is not dependent on renal function.2
Above all, Boehringer is highlighting the how easy the treatment is to use, pointing to a study that has shown it is well accepted by more than 90% of cats.1,3
Martha Cannon, RCVS Specialist in Feline Medicine at the Oxford Cat Clinic, has already used Semintra in cats with CKD. She said: "For us at the Oxford Cat Clinic, ease of use is an enormously important part of any product that we use for cats. From our personal experience, we found that Semintra is very well accepted by cats, with owners finding it very easy to give and to build into their cat's daily treatment plan."
Semintra is available from veterinary wholesalers as a 4mg/ml oral solution. There is one 30 ml bottle size which will last the average 4kg cat 30 days.
A few CKD facts provided by Boehringer:
For further information on Semintra visit www.semintra.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
The RCVS Council has approved the new Strategic Plan designed to bring the College closer to its vision of enhancing society through improved animal health and welfare, over the next three years.
The Strategic Plan is founded on feedback from the profession and the public about what the College does well and where it could do better, and an analysis of how other leading regulators operate. It includes 35 actions, clustered under five themes, all centred on the purpose of setting, upholding and advancing veterinary standards.
For example, the College aims to introduce a service charter - for the public and the profession - of rights, expectations and responsibilities for each of its functions.
Nick Stace, RCVS CEO said: "This drive for excellent service lies at the heart of our focus on improvement.
"The concept of veterinary surgeons and veterinary nurses, as well as the public, being our 'customers', was one that unsettled the profession when it was first mooted. But I believe that only by ensuring that we focus relentlessly on improving how we interact with our customers will we deliver a service for the profession, the public, and, ultimately, the UK's animals, which is worthy of the name first-rate regulator."
Amongst other things, the Plan also commits to:
The Strategic Plan can be downloaded from www.rcvs.org.uk/strategy.
Also at its November meeting, Council approved:
More information on all of these topics will be available in the November issue of RCVS News, online shortly at www.rcvs.org.uk/publications.
You can also hear direct from the CEO via his post-Council video update: www.youtube.com/rcvsvideos.
The Centre of Applied Pet Ethology (COAPE) has announced that its first students have completed the COAPE Level 4 Diploma in the Principles of Companion Animal Behaviour and Training and the COAPE Level 5 Diploma in the Practical Applications of Companion Animal Behaviour and Training.
The qualifications are the first and currently only Ofqual-regulated qualifications for those working in the field of companion animal behaviour and training, and these are the first students to achieve the new qualification.
COAPE Co-Director, Prof. Peter Neville said "We are enormously proud of the successful students, 35 at Level 4 and 21 at Level 5, and wishes them all the very best as they embark on their professional careers and pursuits in the field of canine and feline behaviour, be it as behaviourists, trainers or adding to their present roles as veterinary nurses, veterinarians, assistance dog trainers, animal welfare professionals etc."
COAPE Co-Director, Robert Falconer-Taylor, BVetMed, DipCABT, MRCVS said "Our successful students are the first to be awarded these bespoke qualifications and to have validation and recognition of their ability to help owners and their pets, and especially those to be referred by veterinary practices. In addition they have the ongoing support, mentoring and CPD opportunities available to them as members of the COAPE Association of Pet Behaviourists and Trainers (CAPBT)".
Val Strong (Co-Director of COAPE) said: "This is a historic moment for both COAPE and our awarding body but more importantly for our students. It is also a landmark step in the field of Companion Animal Behaviour and Training Education that is of vital importance for veterinary practices in helping them identify people who have successfully completed a qualification specifically designed for those working in the field of companion animal behaviour and training.
Practices interested in the qualifications for developing behaviour referrals, or their career enhancement value for nurses, visit: http://www.coape.org
The British Small Animal Veterinary Association is using European Antibiotics Awareness Day (today) to highlight its guidance on the appropriate use of antimicrobials.
European Antibiotic Awareness Day is an annual campaign held to raise awareness of prudent antibiotic use and the threat of antibiotic resistance. While in the past it has focused on use of antibiotics in human healthcare, there is an increasing realisation that antimicrobial resistance is a 'One Health' issue with implications for human and animal health as well as the environment.
Professor Michael Day, BSAVA President said: "For both veterinary professionals and those working in human health, the spread of multi-drug resistant bacteria means that we may reach the point where we can no longer treat every day infections or diseases. So the responsible use of antimicrobials is an important focus for this pan-European campaign.
"Antibacterial resistance is now a politically important topic for our profession, and there are those who wish to restrict veterinary use of certain antibacterial products, which could have significant implications for animal health and welfare. It is therefore essential that veterinary surgeons are seen to be using antimicrobials responsibly."